John Stansel
Stock Analyst at JP Morgan
(2.21)
# 3,697
Out of 5,182 analysts
14
Total ratings
71.43%
Success rate
3.84%
Average return
Main Sectors:
Stocks Rated by John Stansel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNC Centene | Maintains: Neutral | $45 → $41 | $53.34 | -23.13% | 5 | Mar 19, 2026 | |
| HSIC Henry Schein | Maintains: Overweight | $78 → $92 | $73.93 | +24.44% | 2 | Feb 25, 2026 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $23 → $26 | $20.26 | +28.33% | 2 | Feb 5, 2026 | |
| MOH Molina Healthcare | Maintains: Neutral | $272 → $184 | $192.70 | -4.51% | 2 | Jul 29, 2025 | |
| DGX Quest Diagnostics | Maintains: Neutral | $148 → $149 | $192.67 | -22.67% | 1 | Nov 17, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $259 → $261 | $255.84 | +2.02% | 1 | Nov 17, 2023 | |
| ONON On Holding AG | Initiates: Buy | $31 | $34.54 | -10.25% | 1 | Apr 19, 2022 |
Centene
Mar 19, 2026
Maintains: Neutral
Price Target: $45 → $41
Current: $53.34
Upside: -23.13%
Henry Schein
Feb 25, 2026
Maintains: Overweight
Price Target: $78 → $92
Current: $73.93
Upside: +24.44%
Alignment Healthcare
Feb 5, 2026
Maintains: Overweight
Price Target: $23 → $26
Current: $20.26
Upside: +28.33%
Molina Healthcare
Jul 29, 2025
Maintains: Neutral
Price Target: $272 → $184
Current: $192.70
Upside: -4.51%
Quest Diagnostics
Nov 17, 2023
Maintains: Neutral
Price Target: $148 → $149
Current: $192.67
Upside: -22.67%
Labcorp Holdings
Nov 17, 2023
Maintains: Overweight
Price Target: $259 → $261
Current: $255.84
Upside: +2.02%
On Holding AG
Apr 19, 2022
Initiates: Buy
Price Target: $31
Current: $34.54
Upside: -10.25%